Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival

This publication has 25 references indexed in Scilit:

• Combination chemotherapy of hepatocellular carcinoma with doxorubicin and streptozotocin
  American Journal of Clinical Oncology, 1983
• Evaluation of weekly escalating doses of dichloromethotrexate in patients with hepatocellular carcinoma and other solid tumors
  Cancer Chemotherapy and Pharmacology, 1982
• Hepatocellular Carcinoma in Rural Southern African Blacks
  Medicine, 1982
• Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features
  Cancer, 1980
• ORAL-CONTRACEPTIVE-ASSOCIATED LIVER TUMOURS: OCCURRENCE OF MALIGNANCY AND DIFFICULTIES IN DIAGNOSIS
  The Lancet, 1980
• INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICIN
  The Lancet, 1978
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
  British Journal of Cancer, 1977
• The variable course of primary hepatocellular carcinoma
  British Journal of Surgery, 1974
• Evaluation of Response-Time Data Involving Transient States: An Illustration Using Heart-Transplant Data
  Journal of the American Statistical Association, 1974
• SERUM-ALPHA-FETOPROTEIN LEVELS IN PATIENTS WITH ATAXIA-TELANGIECTASIA
  The Lancet, 1972